We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Par’s Generic Ultram ER Approved by the FDA
Par’s Generic Ultram ER Approved by the FDA
November 20, 2009
Par Pharmaceutical won FDA approval and 180 days of marketing exclusivity for a generic version of Ortho-McNeil’s pain-management drug Ultram extended
release (ER).